Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer (vol 34, pg 3740, 2016)

被引：0
|
作者：
Reck
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 34期
关键词：
D O I：
10.1200/JCO.19.02803
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3327 / 3327
页数：1
相关论文
共 50 条
  • [1] Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
    Reck, Martin
    Luft, Alexander
    Szczesna, Aleksandra
    Havel, Libor
    Kim, Sang-We
    Akerley, Wallace
    Pietanza, Maria Catherine
    Wu, Yi-long
    Zielinski, Christoph
    Thomas, Michael
    Felip, Enriqueta
    Gold, Kathryn
    Horn, Leora
    Aerts, Joachim
    Nakagawa, Kazuhiko
    Lorigan, Paul
    Pieters, Anne
    Sanchez, Teresa Kong
    Fairchild, Justin
    Spigel, David
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3740 - +
  • [2] First-Line Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide for Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis
    Zhang, Longfeng
    Hang, Yongfu
    Liu, Maobai
    Li, Na
    Cai, Hongfu
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial
    Hermes, Andreas
    Bergman, Bengt
    Bremnes, Roy
    Ek, Lars
    Fluge, Sverre
    Sederholm, Christer
    Sundstrom, Stein
    Thaning, Lars
    Vilsvik, Jan
    Aasebo, Ulf
    Soerenson, Sverre
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4261 - 4267
  • [4] Survival and Toxicity After Cisplatin Plus Etoposide Versus Carboplatin Plus Etoposide for Extensive-Stage Small-Cell Lung Cancer in Elderly Patients
    Hatfield, Laura A.
    Huskamp, Haiden A.
    Lamont, Elizabeth B.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (07) : 665 - +
  • [5] First-line atezolizumab/durvalumab plus platinum–etoposide combined with radiotherapy in extensive-stage small-cell lung cancer
    Lijuan Li
    Dan Yang
    Yanmei Min
    Anyan Liao
    Jing Zhao
    Leilei Jiang
    Xin Dong
    Wei Deng
    Huiming Yu
    Rong Yu
    Jun Zhao
    Anhui Shi
    BMC Cancer, 23
  • [6] Safety and efficacy of darbepoetin alfa in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide
    Pirker, Robert
    Ramlau, Rodryg A.
    Schuette, Wolfgang
    Zatloukal, Petr
    Ferreira, Irene
    Lillie, Tom
    Vansteenkiste, Johan F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2342 - 2349
  • [7] Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer
    Lara, Primo N., Jr.
    Gandara, David R.
    Natale, Ronald B.
    CLINICAL LUNG CANCER, 2006, 7 (05) : 353 - 356
  • [8] Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
    Paz-Ares, Luis
    Dvorkin, Mikhail
    Chen, Yuanbin
    Reinmuth, Niels
    Hotta, Katsuyuki
    Trukhin, Dmytro
    Statsenko, Galina
    Hochmair, Maximilian J.
    Ozguroglu, Mustafa
    Ji, Jun Ho
    Voitko, Oleksandr
    Poltoratskiy, Artem
    Ponce, Santiago
    Verderame, Francesco
    Havel, Libor
    Bondarenko, Igor
    Kazarnowicz, Andrzej
    Losonczy, Gyorgy
    Conev, Nikolay V.
    Armstrong, Jon
    Byrne, Natalie
    Shire, Norah
    Jiang, Haiyi
    Goldman, Jonathan W.
    Batagelj, Emilio
    Casarini, Ignacio
    Pastor, Anea Viviana
    Sena, Susana Noemi
    Zarba, Juan Jose
    Burghuber, Otto
    Hartl, Sylvia
    Hochmair, Maximilian J.
    Lamprecht, Bernd
    Studnicka, Michael
    Schlittler, Luis Alberto
    de Oliveira, Fabricio Augusto Martinelli
    Calabrich, Aknar
    Girotto, Gustavo Colagiovanni
    Dos Reis, Peo
    Gorini, Carlos Fausto Nino
    De Marchi, Peo Rafael Martins
    Baldotto, Clarissa Serodio da Rocha
    Sette, Claudia
    Zukin, Mauro
    Conev, Nikolay V.
    Dudov, Assen
    Ilieva, Rumyana
    Koynov, Krassimir
    Krasteva, Rositsa
    Tonev, Ivan
    LANCET, 2019, 394 (10212): : 1929 - 1939
  • [9] RANDOMIZED COMPARISON OF LOBAPLATIN PLUS ETOPOSIDE AND CISPLATIN PLUS ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER
    Guo, Feng W.
    Liao, Qing G.
    Gao, Jun H.
    Wang, Mei H.
    Tang, Hao C.
    Qing, Peng H.
    Li, Jie J.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S493 - S493
  • [10] Phase II Study of Pembrolizumab, Plinabulin plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer
    Huang, Y.
    Tong, F.
    Zhang, R.
    Liu, P.
    Dong, X.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S704 - S705
12345